Variables | HR (95% CI) | P-value |
---|---|---|
Gender | ||
Male | Reference | |
Female | 1.41(0.69–2.90) | 0.301 |
Age | 0.98 (0.93–1.02) | 0.254 |
T | ||
T1 | Reference | |
T2 | 11.79 (0.89–156.00) | 0.061 |
T3 | 7.72 (0.48–124.14) | 0.149 |
T4 | 14.73 (0.86–253.18) | 0.064 |
N | ||
N0 | Reference | |
N1 | 8.34 (1.59–43.80) | 0.012 |
N2 | 12.38 (2.18–70.22) | 0.004 |
N3a | 8.45 (1.31–54.62) | 0.025 |
N3b | 10.35 (1.52–70.23) | 0.017 |
Tumor Grade | ||
well | Reference | |
moderately | 0.49 (0.05–4.81) | 0.537 |
poorly | 0.65 (0.07–6.36) | 0.71 |
Chemotherapy | ||
Yes | Reference | |
No | 0.57 (0.21–1.54) | 0.264 |
TNM | 3.899 (2.62–5.18) | < 0.001 |
LNR | 2.40 (1.21–3.59) | 0.028 |
Primary malignant disease | ||
No | Reference | |
Yes | 1.06 (0.55–2.05) | 0.9 |